A test of physical function called Glittre-ADL may be better than the standard six-minute walk test at identifying physical limitations…
Articles by Marisa Wexler, MS
Treatment with Trikafta (ivacaftor/tezacaftor/elexacaftor) eases nose and sinus symptoms in eligible patients with cystic fibrosis (CF), and the…
A five-year study led by scientists at Emory University in Georgia aims to identify new ways to improve quality of…
A novel treatment strategy for cystic fibrosis (CF) that’s based on a cellular structure called the porosome showed promise…
Biopharma and biotech companies have launched more than 450 clinical trials into potential new treatments for cystic fibrosis (CF)…
The CFTR modulator therapy Kalydeco (ivacaftor) can safely be given to babies with cystic fibrosis (CF) as young…
While Kaftrio — sold as Trikafta in North America — can improve lung function in children with cystic…
Mutations that cause cystic fibrosis (CF) lead to biochemical changes in lung cells that make it easier for infectious…
The U.S. Food and Drug Administration (FDA) has given the go-ahead for a Phase 2 trial testing the inhalation therapy…
For adults with cystic fibrosis (CF), the symptoms with the biggest impact on quality of life include pain, fatigue,…